KR100690071B1 - Functional composition for the prevention and improvement of hangover - Google Patents
Functional composition for the prevention and improvement of hangover Download PDFInfo
- Publication number
- KR100690071B1 KR100690071B1 KR1020050086889A KR20050086889A KR100690071B1 KR 100690071 B1 KR100690071 B1 KR 100690071B1 KR 1020050086889 A KR1020050086889 A KR 1020050086889A KR 20050086889 A KR20050086889 A KR 20050086889A KR 100690071 B1 KR100690071 B1 KR 100690071B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- weight
- hangover
- vitamin
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 206010019133 Hangover Diseases 0.000 title claims abstract description 45
- 230000006872 improvement Effects 0.000 title abstract description 3
- 230000002265 prevention Effects 0.000 title abstract description 3
- 239000000284 extract Substances 0.000 claims abstract description 82
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 26
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims abstract description 23
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229940030275 epigallocatechin gallate Drugs 0.000 claims abstract description 22
- 241000508269 Psidium Species 0.000 claims abstract description 20
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 17
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 17
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 16
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 16
- 241000018646 Pinus brutia Species 0.000 claims abstract description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 13
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 13
- 239000011718 vitamin C Substances 0.000 claims abstract description 13
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 12
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 16
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 11
- 229940096421 milk thistle extract Drugs 0.000 claims description 10
- 235000020727 milk thistle extract Nutrition 0.000 claims description 10
- 244000186892 Aloe vera Species 0.000 claims 1
- 241000269837 Artemisia dubia Species 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 55
- 235000019441 ethanol Nutrition 0.000 abstract description 40
- 244000144927 Aloe barbadensis Species 0.000 abstract description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 14
- 241001465754 Metazoa Species 0.000 abstract description 7
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 abstract description 6
- 235000010841 Silybum marianum Nutrition 0.000 abstract description 6
- 241000320380 Silybum Species 0.000 abstract description 5
- 239000012046 mixed solvent Substances 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 abstract description 3
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 2
- 241000092668 Artemisia capillaris Species 0.000 abstract 2
- 241000222355 Trametes versicolor Species 0.000 abstract 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- 244000236580 Psidium pyriferum Species 0.000 abstract 1
- 235000013929 Psidium pyriferum Nutrition 0.000 abstract 1
- 244000272459 Silybum marianum Species 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 28
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- 235000013305 food Nutrition 0.000 description 20
- 235000013361 beverage Nutrition 0.000 description 16
- 239000000499 gel Substances 0.000 description 16
- 239000000523 sample Substances 0.000 description 15
- 239000004615 ingredient Substances 0.000 description 14
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 240000006891 Artemisia vulgaris Species 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 239000002075 main ingredient Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 241000700159 Rattus Species 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000015872 dietary supplement Nutrition 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 235000013373 food additive Nutrition 0.000 description 6
- 239000002778 food additive Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 241000208340 Araliaceae Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 description 5
- 230000035622 drinking Effects 0.000 description 5
- 235000013376 functional food Nutrition 0.000 description 5
- 235000008434 ginseng Nutrition 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 3
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 229940119569 wormwood extract Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 2
- 235000003097 Artemisia absinthium Nutrition 0.000 description 2
- 240000001851 Artemisia dracunculus Species 0.000 description 2
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 239000001138 artemisia absinthium Substances 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000013622 meat product Nutrition 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000605411 Lloydia Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
- 244000136948 Ocimum sanctum Species 0.000 description 1
- 235000004072 Ocimum sanctum Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 244000172730 Rubus fruticosus Species 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000755330 Tinospora malabarica Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- CQAIPTBBCVQRMD-UHFFFAOYSA-L dipotassium;phosphono phosphate Chemical compound [K+].[K+].OP(O)(=O)OP([O-])([O-])=O CQAIPTBBCVQRMD-UHFFFAOYSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Polymers [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 235000021264 seasoned food Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000000053 special nutrition Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
Abstract
Description
도 1은 본 발명의 기능성 조성물의 혈중 알코올 농도 감소 효과를 측정한 동물실험 결과도이고,1 is a result of animal experiments measuring the effect of reducing the blood alcohol concentration of the functional composition of the present invention,
도 2는 기능성 조성물의 숙취해소 효능에 대한 임상실험 결과도이다.Figure 2 is a clinical test result for the hangover efficacy of the functional composition.
본 발명은 음주로 인한 숙취를 해소시키는 효과를 갖는 기능성 조성물에 관한 것으로, 알로에베라겔, 에피갈로카테킨갈레이트(EGCG), 솔잎 추출물, 구아바잎 추출물, 비타민 C, 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 하고, 밀크티슬(Milk thistle) 추출물, 인진쑥 추출물 및 운지버섯 추출물로 이루어진 군으로부터 선택된 조합을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물에 관한 것이다. The present invention relates to a functional composition having an effect of eliminating hangover caused by drinking, selected from the group consisting of aloe vera gel, epigallocatechin gallate (EGCG), pine needle extract, guava leaf extract, vitamin C, vitamin B 2 The present invention relates to a functional composition for preventing and improving hangover, comprising as a main ingredient a combination selected from the group consisting of milk thistle extract, jinjin wormwood extract, and fingering mushroom extract.
회식과 접대가 잦고 스트레스가 많은 현대인들에게 음주는 필수적인 것으로 자리잡고 있으며, 과다한 음주는 일시적으로 두근거림, 두통, 갈증, 멀미, 위장장애, 설사 등의 숙취현상(hangover)을 유발한다.Drinking is becoming essential for modern people who are frequent for dinner, entertainment and stress. Excessive drinking temporarily causes hangovers such as palpitations, headaches, thirst, motion sickness, stomach upset, and diarrhea.
따라서, 예전부터 에탄올의 독성을 경감시키거나 독성의 발현을 저해할 수 있는 많은 물질에 대한 연구와 실험이 진행되어 왔으며, 그 결과, 그와 관련된 천연식품이나 한약재료로부터 추출한 성분을 함유한 다양한 건강보조식품이 개발되고 있다(김정한 등, 한국농화학회지, 38(6), pp549-553, 1995).Therefore, researches and experiments have been conducted on many substances that can reduce the toxicity of ethanol or inhibit the expression of toxic substances. As a result, various health products containing ingredients extracted from related natural foods or herbal medicines have been conducted. Supplements are being developed (Kim Jung-han et al., Korean Journal of Agricultural Chemistry, 38 (6) , pp549-553, 1995).
최근 들어, 한약제 또는 민간요법제로서 숙취해소에 유용한 효과가 있다고 알려져 있는 인삼, 가시오가피 등의 성분을 주성분으로 하는 각종 제제 형태의 기능성 식품들이 개발되었다. 그 중 인삼을 주성분으로 하는 자양강장 드링크제가 다수 시판되고 있으며, 기타 꿀, 비타민 등의 각종 성분들도 적당량의 함량으로 조성하여 자양강장제로 시판되고 있다. 인삼, 가시오가피(Brekhman et al., Lloydia, 32(1), pp46-51, 1969), 오씨뭄(Ocimum sanctum Linn), 티노스포라말라바리카 (tinosporamalabarica)(Sen, P. et al., Indian J. Exp . Biol ., 30, pp592-596, 1992) 등의 생약과 멜라토닌 등의 생체물질이 숙취해소 작용을 나타낸다고 보고되어 있기는 하나, 음주에 의해 유발되는 다양한 숙취증상 중에서 일부 증상에만 효과가 있거나 숙취해소 효과가 미미한 것으로 나타났다. 얼마 전부터는 콩나물을 주원료한 식물 엑기스를 함유한 제품과 미배아와 대두 추출물을 함유한 제품이 소개되고 있다. 그러나, 이들 역시 제제의 안전성 면에서 여전히 해결해야 할 많은 문제점이 지적되었다. Recently, functional foods in the form of various preparations based on ingredients such as ginseng and thorny ginseng are known to have a beneficial effect on hangover as a herbal or folk remedy. Among them, a number of nourishing tonic drinks are mainly marketed as ginseng, and various ingredients such as honey and vitamins are also marketed as nourishing tonic. Ginseng, bramble (Brekhman et al ., Lloydia , 32 (1) , pp46-51, 1969), Ocimum sanctum Linn), tinosporamalabarica (Sen, P. et al., Indian J. Exp . Biol . , 30 , pp592-596, 1992) and biomaterials such as melatonin to hangover Although it has been reported to indicate, among the various hangover symptoms caused by drinking alcohol, it is effective only in some symptoms or has a small hangover effect. Recently, products containing plant extracts mainly containing soybean sprouts and products containing embryonic and soybean extracts have been introduced. However, they also point out a number of problems that still need to be addressed in terms of the safety of the formulation.
이와 같이 음주 후의 숙취제거를 위하여 각종 생약제를 포함하는 드링크제가 시판되고 있으나, 일부 생약제를 함유하는 드링크제는 전신권태, 복부팽만감, 구토 또는 복통 등을 유발하는 경우가 있을 뿐 아니라, 일부 드링크제는 고가의 생약제를 사용함으로써 고가로 판매되는 등의 문제점이 있다.As such, drink preparations containing various herbal medicines are commercially available for eliminating hangovers after drinking alcohol. However, drink preparations containing some herbal medicines may cause systemic boredom, bloating, vomiting or abdominal pain, and some drink preparations are expensive. There is a problem such as selling at high prices by using a herbal medicine.
이에 본 발명자들은 상기에서 서술한 바와 같이 현대인들의 음주에 대한 폐해를 동시에 해결하여 활기찬 일상생활을 유지할 수 있도록 하기 위하여 인체에 부작용이 없으면서 숙취 예방 및 개선할 수 있는 기능성 조성물을 개발하였다. Accordingly, the present inventors have developed a functional composition capable of preventing and improving hangovers without side effects in the human body in order to maintain the lively daily life by simultaneously solving the harmful effects of modern people drinking as described above.
따라서, 본 발명의 목적은 인체에 부작용이 없으면서 숙취 해소에 효과적인 조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a composition effective in relieving hangovers without any side effects on the human body.
상기 목적을 달성하기 위하여, 본 발명은 음주로 인한 숙취를 해소시키는 효과를 갖는 기능성 조성물을 제공한다. 보다 상세하게는 알로에베라겔, 에피갈로카테킨갈레이트(EGCG), 솔잎 추출물, 구아바잎 추출물, 비타민 C, 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 함유하는 숙취 예방 및 개선용 기능성 조성물을 제공한다. In order to achieve the above object, the present invention provides a functional composition having the effect of eliminating the hangover caused by drinking. More specifically, it provides a functional composition for preventing and improving hangover containing aloe vera gel, epigallocatechin gallate (EGCG), pine needle extract, guava leaf extract, vitamin C, and a combination selected from the group consisting of vitamin B 2 as a main ingredient. do.
상기 조성물은 알로에베라겔 추출물, 에피갈로카테킨갈레이트(EGCG), 솔잎 추출물, 구아바잎 추출물, 비타민 C 및 비타민 B2를 주성분으로 함유하는 숙취 예방 및 개선용 기능성 조성물을 포함한다. The composition includes a functional composition for preventing and improving hangover containing aloe vera gel extract, epigallocatechin gallate (EGCG), pine needle extract, guava leaf extract, vitamin C and vitamin B 2 as main ingredients.
또한, 상기 조성물에 밀크티슬(Milk thistle) 추출물, 인진쑥 추출물 및 운지버섯 추출물로 이루어진 군으로부터 선택된 조합을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물을 제공한다.The present invention also provides a functional composition for preventing and improving hangover, which comprises a combination selected from the group consisting of milk thistle extract, jinjin wormwood extract, and fingerling mushroom extract as additional ingredients.
상기 조합은 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물인 기능성 조성물을 포함한다.The combination includes a functional composition which is a milk thistle extract, jinjin worm extract, fingerling mushroom extract.
상기 추출물은 물, 에탄올, 메탄올, 부탄올과 같은 저급 알콜 또는 이들의 혼합용매, 바람직하게는 메탄올에 가용한 추출물을 포함한다.The extracts include water, ethanol, methanol, lower alcohols such as butanol or mixtures thereof, preferably extracts soluble in methanol.
상기 주성분은 알로에베라겔 추출물 20 - 40 중량 %, 에피갈로카테킨갈레이트(EGCG) 1 - 10 중량 %, 솔잎추출물 10 - 30 중량 %, 구아바잎 추출물 5 - 20 중량 %, 비타민C 0.5 - 5 중량 %, 비타민B2 0.5 - 5 중량 %로 이루어진 것을 특징으로 한다.The main ingredient is 20-40% by weight of Aloe vera gel extract, 1-10% by weight of epigallocatechin gallate (EGCG), 10-30% by weight of pine needle extract, 5-20% by weight of guava leaf extract, 0.5-5% by weight of vitamin C. %, Vitamin B 2 It is characterized by consisting of 0.5 to 5% by weight.
상기 부가성분으로 포함되는 성분은 밀크티슬 추출물 5 - 20 중량 %, 인진쑥 추출물 1 - 10 중량 %, 운지버섯 추출물 1 - 15 중량 %로 이루어진 것을 특징으로 한다.Ingredients included as the additional component is characterized in that consisting of 5-20% by weight of milk Thistle extract, 1-10% by weight of the jinjin mugwort extract, 1-15% by weight fingering mushroom extract.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 알로에베라겔 추출물, 솔잎 추출물, 구아바잎 추출물, 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물은 하기와 같이 수득될 수 있다.Aloe vera gel extract, pine needle extract, guava leaf extract, milk Thistle extract, jinjin worm extract, fingerling mushroom extract of the present invention can be obtained as follows.
먼저, 알로에베라겔, 솔잎, 구아바잎, 밀크티슬, 인진쑥, 운지버섯을 각각 건조 후 마쇄하여 분말화 한 후, 각 건조 중량의 약 2 내지 20 배, 바람직하게는 약 3 내지 7 배에 달하는 부피의 물, 메탄올, 에탄올 및 부탄올과 같은 저급 알콜 또는 이들의 약 1:0.1 내지 1:10의 혼합비를 갖는 혼합용매, 바람직하게는 물로 20 내지 100 ℃, 바람직하게는 60 내지 80 ℃의 추출 온도에서 약 0.5시간 내지 2일, 바람직하게는 1 시간 내지 1일 동안 일정시간 간격으로, 열수 추출, 냉침 추출, 환류 냉각 추출 또는 초음파 추출 등의 추출방법, 바람직하게는 열수 추출로 1회 내지 5회, 바람직하게는 3회 연속 추출하여 감압여과하고 여과추출물을 진공회전농축기로 20 내지 100 ℃, 바람직하게는 20 내지 70 ℃에서 감압농축하여 물, 저급알콜 또는 이들의 혼합용매에 가용한 각 추출물을 수득할 수 있다.First, aloe vera gel, pine needles, guava leaf, milk thistle, phosphorus mugwort, and fingerling mushrooms are dried and pulverized, respectively, and then powdered, and then each volume is about 2 to 20 times, preferably about 3 to 7 times the dry weight. Lower alcohols such as water, methanol, ethanol and butanol, or mixed solvents having a mixing ratio of about 1: 0.1 to 1:10, preferably about 20 to 100 ° C, preferably about 60 to 80 ° C, with an extraction temperature of about 0.5 hours to 2 days, preferably 1 hour to 1 day at a predetermined time interval, extraction method such as hot water extraction, cold extraction, reflux cooling extraction or ultrasonic extraction, preferably 1 to 5 times by hot water extraction, preferably Preferably, the extract is filtered three times under reduced pressure, and the filtrate is concentrated under reduced pressure at 20 to 100 ° C., preferably at 20 to 70 ° C., using a vacuum rotary concentrator to extract water, lower alcohol, or a mixed solvent thereof. Can be obtained.
또한, 본 발명은 상기 방법으로 수득한 알로에베라겔 추출물, 솔잎 추출물과 에피갈로카테킨갈레이트(EGCG), 구아바잎 추출물, 비타민 C 및 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 하고, 상기 방법으로 수득한 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물로 이루어진 군으로부터 선택된 조합을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물 외에 기타 식품 성분을 함유하는 식품을 제공한다.In addition, the present invention, the aloe vera gel extract, pine needle extract and epigallocatechin gallate (EGCG), guava leaf extract, vitamin C and vitamin B 2 obtained by the above method as a main component, the method It provides a food containing other food ingredients in addition to the functional composition for preventing and improving a hangover comprising a combination selected from the group consisting of milk thistle extract, phosphorus mugwort extract, finger finger mushroom extract obtained as an additional ingredient.
상기 식품은 과자류, 당류, 아이스크림 제품류, 유가공품, 식육제품, 어육제품, 두부류 또는 묵류, 식용유지류, 면류, 다류, 음료류, 특수영양식품, 건강보조식품, 조미식품, 얼음, 인삼제품류, 김치절임식품, 건포류 외 기타 식품류를 포함한다.The food is confectionary, sugar, ice cream products, dairy products, meat products, fish meat products, tofu or jelly, edible oils and fats, noodles, teas, beverages, special nutrition products, health supplements, seasoned foods, ice, ginseng products, pickles And raisins and other foodstuffs.
한편, 상기 식품의 형태는 분말, 과립, 정제, 캡슐, 액상 또는 음료 형태를 포함한다.Meanwhile, the form of the food includes powder, granule, tablet, capsule, liquid or beverage form.
또한, 본 발명은 알로에베라겔 추출물, 솔이 추출물과 에피갈로카테킨갈레이트(EGCG), 구아바잎 추출물, 비타민 C 및 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 하고, 상기 방법으로 수득한 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물로 이루어진 군으로부터 선택된 조합을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물 식품첨가제를 제공한다.In addition, the present invention is a milk tease obtained by the aloe vera gel extract, a sol extract and epigallocatechin gallate (EGCG), guava leaf extract, a combination selected from the group consisting of vitamin C and vitamin B 2 as a main ingredient, It provides a functional composition food additive for preventing and improving a hangover comprising a combination selected from the group consisting of extracts, jinjin wormwood extract, finger finger mushroom extract as an additional ingredient.
상기 식품첨가제는 분말, 과립, 정제, 캡슐, 액상 또는 음료 형태를 포함한다.The food additives include powders, granules, tablets, capsules, liquid or beverage forms.
또한, 본 발명은 상기의 식품첨가제를 식품에 살균제, 향신료, 조미제, 여러가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등 또는 식품소재의 필수원료로 사용하는 것을 특징으로 하는 식품첨가제의 이용방법을 제공한다. 이때 식품첨가제는 식품을 침지, 분무 또는 혼합하여 상기 식품에 첨가할 수 있으며, 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 조성물 100 중량부 당 0 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다.In addition, the present invention, the food additives in the food, such as fungicides, spices, seasonings, various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, such as colorants and neutralizing agents (cheese, chocolate, etc.) ), Pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloid thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, or the like as essential raw materials for food materials It provides a method of using a food additive characterized in that. In this case, the food additive may be added to the food by dipping, spraying or mixing the food, and the ratio of such additive is not so important, but it is generally selected from 0 to about 20 parts by weight per 100 parts by weight of the composition of the present invention. .
식품은 과일, 야채, 과일이나 야채의 건조제품이나 절단제품, 과일쥬스, 야채쥬스, 이들의 혼합쥬스이거나 칩류, 면류, 축산가공식품, 수산가공식품, 유가공식품, 발 효유식품, 두류식품, 곡류식품, 미생물발효식품, 제과제빵, 양념류, 육가공류, 산성음료수, 감초류, 허브류 중 어느 하나 또는 하나 이상이다.Foods are fruits, vegetables, dried or cut products of fruits or vegetables, fruit juices, vegetable juices, mixed juices of these, chips, noodles, livestock processed foods, fish processed foods, dairy products, fermented milk foods, legumes food, cereals One or more of food, microbial fermented food, bakery, condiments, meat processing, acidic beverages, licorice, herbs.
또한, 본 발명은 알로에베라겔 추출물, 솔잎 추출물과 에피갈로카테킨갈레이트(EGCG), 구아바잎 추출물, 비타민 C 및 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 하고, 상기 방법으로 수득한 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물로 이루어진 군으로부터 선택된 조합을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물 외에 식품학적으로 허용가능한 식품보조첨가제를 포함하는 건강기능식품을 제공한다.The present invention also comprises aloe vera gel extract, pine needle extract and epigallocatechin gallate (EGCG), guava leaf extract, vitamin C and vitamin B 2 , the milk ingredient obtained by the above method as a main ingredient It provides a health functional food comprising a food supplement acceptable food supplements in addition to the functional composition for preventing and improving a hangover comprising as an additional ingredient a combination selected from the group consisting of extracts, Injin mugwort extract, fingerling mushroom extract.
상기 건강기능식품은 분말, 과립, 정제, 캡슐 또는 음료 형태인 건강기능식품을 포함한다.The dietary supplement includes a dietary supplement in the form of a powder, granule, tablet, capsule or beverage.
본 발명은 숙취 예방 및 개선 효과를 나타내는 상기 조성물 및 식품학적으로 허용 가능한 식품보조 첨가제를 포함하는 건강기능식품을 제공한다. 상기 조성물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 건강기능 식품류 등이 있다. The present invention provides a health functional food comprising the composition and a food acceptable food supplement additive exhibiting a hangover prevention and improvement effect. Examples of the food to which the composition can be added include various foods, beverages, gums, teas, vitamin complexes, and health functional foods.
또한, 숙취 예방 및 개선을 목적으로 식품 또는 음료에 첨가될 수 있다. 이 때, 식품 또는 음료 중의 상기 조성물의 양은, 일반적으로 본 발명의 건강기능식품 조성물의 경우는 전체 식품 중량의 0.01 내지 15 중량 %, 바람직하게는 0.1 내지 10 중량 %로 가할 수 있으며, 건강 음료 조성물에는 100 ㎖를 기준으로 0.01 ~ 15 g, 바람직하게는 0.1 ~10 g의 비율로 가할 수 있다. It may also be added to food or beverages for the purpose of preventing and improving hangovers. At this time, the amount of the composition in the food or beverage, in general, in the case of the nutraceutical composition of the present invention can be added to 0.01 to 15% by weight, preferably 0.1 to 10% by weight of the total food weight, the health beverage composition It can be added at a ratio of 0.01 to 15 g, preferably 0.1 to 10 g based on 100 ml.
본 발명의 건강 음료 조성물은 지시된 비율로 필수 성분으로서 상기 조성물을 함유하는 외에 액체성분에는 특별한 제한점은 없으며 통상의 음료와 같이 여러가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리스리톨 등의 당알콜이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등), 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖ 당 일반적으로 약 1 ~ 20 g, 바람직하게는 약 5 ~ 12 g이다.The health beverage composition of the present invention, in addition to containing the composition as an essential ingredient in the indicated ratio, is not particularly limited in the liquid component and may contain various flavors or natural carbohydrates, etc. as additional ingredients, as in general beverages. Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And conventional sugars such as polysaccharides such as dextrin, cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents other than those mentioned above, natural flavoring agents (tauumatin, stevia extract (e.g., rebaudioside A, glycyrrhizin, etc.), and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. The ratio of said natural carbohydrate is generally about 1-20 g, preferably about 5-12 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 본 발명의 조성물들은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 조성물 100 중량부 당 0 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다. In addition to the above, the composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese and chocolate), pectic acid and salts thereof, alginic acid and its Salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like. The compositions of the present invention may also contain pulp for the production of natural fruit juices and fruit juice beverages and vegetable beverages. These components can be used independently or in combination. The proportion of such additives is not so critical but is generally selected from the range of 0 to about 20 parts by weight per 100 parts by weight of the composition of the present invention.
본 발명의 조성물에는 구연산, 후말산, 아디픽산, 젖산, 사과산 등의 유기산이나 인산나트륨, 인산칼륨, 산성피로인산염, 폴리인산염(중합인산염) 등의 인산염이나 폴리페놀, 카테킨(catechin), 알파-토코페롤, 로즈메리 추출물(rose mary extract), 감초 추출물, 키토산, 탄닌산, 피틴산 등의 천연 항산화제 중 어느 하나 또는 하나 이상을 추가로 포함할 수 있다.The composition of the present invention includes organic acids such as citric acid, fumaric acid, adipic acid, lactic acid and malic acid, phosphates such as sodium phosphate, potassium phosphate, acid pyrophosphate and polyphosphate (polyphosphate), polyphenols, catechins and alpha- It may further include any one or more of natural antioxidants such as tocopherol, rose mary extract, licorice extract, chitosan, tannic acid, phytic acid.
상기의 조성물은 20 내지 90 % 고농축액이거나 분말이거나 과립형태일 수 있다.The composition may be 20 to 90% high concentrate, powder or granule form.
마찬가지로, 본 발명의 조성물은 유당 카제인, 덱스트린, 포도당, 설탕, 솔비톨 중 어느 하나 또는 하나 이상을 추가로 포함할 수 있다.Likewise, the composition of the present invention may further comprise any one or more of lactose casein, dextrin, glucose, sugar, sorbitol.
이하, 본 발명을 실시예 및 실험예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail by Examples and Experimental Examples.
단, 하기 실시예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 의해 한정되는 것은 아니다.However, the following Examples and Experimental Examples are merely illustrative of the present invention, and the content of the present invention is not limited by the following Examples and Experimental Examples.
실시예Example 1. 추출물의 제조 1. Preparation of Extract
본 발명에 사용한 알로에베라겔, 솔잎, 구아바잎, 밀크티슬, 인진쑥, 운지버섯은 상점 및 경동시장에서 구입하여 사용하였다. 알로에베라겔, 솔잎, 구아바잎, 밀크티슬, 인지쑥, 운지버섯를 각각 1 kg을 건조 후 마쇄하여 얻은 분말 각 300 내지 600 g을 집기병에 담은 후 증류수 2 ℓ를 넣고 70 ℃에서 일정시간 간격(12 h, 6h, 3h)으로 3회 반복하여 열수 추출한 후, 여지(와트만사, 미국)로 감압여과한 다음, 여과 추출물은 진공회전농축기로 40 ℃에서 증류수를 제거한 후 추출된 잔사로써 각 추출물 50 내지 200 g을 수득하였다. Aloe vera gel, pine needles, guava leaf, milk thistle, jinjin wormwood, and fingering mushrooms used in the present invention were used in stores and Gyeongdong market. After drying 1 kg of aloe vera gel, pine needles, guava leaf, milk thistle, ginko wormwood, and fingering mushrooms, each 300 to 600 g of powder obtained by grinding and crushing was put in a household jar, and 2 liters of distilled water was added at a predetermined time interval (12 h , 6h, 3h) was extracted three times with hot water, filtered under reduced pressure with a filter paper (Watman, USA), and then the filtrate extract was extracted with distilled water at 40 ° C. with a vacuum rotary concentrator. g was obtained.
각 후보물질 농축액은 4℃보관 농축시료로서 혹은 디스크타입 분무건조(spray dryer), 또는 동결건조(freezing dryer)를 이용하여 분말형태로 준비하여 시료로 준비할 수 있으며 건조된 분말시료는 수분흡수를 억제된 상태로 보관하였다.Each candidate concentrate can be prepared as a sample using a concentrated sample stored at 4 ° C, or in the form of a powder using a disk-type spray dryer or freezing dryer. Stored in a restrained state.
실시예Example 2. 기능성 조성물의 제조 2. Preparation of Functional Composition
상기 실시예 1에서 수득한 알로에베라겔 추출물 20 - 40 중량 %, 솔잎 추출물 10 - 30 중량 %과 에피갈로카테킨갈레이트(EGCG) 1 - 10 중량 %, 구아바잎 추출물 5 - 20 중량 %, 비타민 C 0.5 - 5 중량 % 및 비타민 B2 0.5 -5 중량 %를 주성분으로 하고, 상기 실시예 1에서 수득한 밀크티슬 추출물 5 - 20 중량 %, 인진쑥 추출물 1 - 10 중량 %, 운지버섯 추출물 1 - 15 중량 % 를 부가성분으로 하고 이를 혼합하여 기능성 조성물을 제조하였다.Aloe vera gel extract obtained in Example 1 20-40% by weight, pine needle extract 10-30% by weight and epigallocatechin gallate (EGCG) 1-10% by weight, guava leaf extract 5-20% by weight, vitamin C 0.5-5% by weight and 0.5-5% by weight of vitamin B 2 as a main ingredient, 5-20% by weight of the milk thistle extract obtained in Example 1, 1-10% by weight of the Mugwort extract, 1-15% by fingerling mushroom extract A functional composition was prepared by adding% as an additive ingredient and mixing them.
실험예Experimental Example 1. One. 천연물질군에서In the natural substance group 알코올 분해효소( Alcohol degrading enzymes ( ADHADH ) 및 아세트알데히드 분해효소() And acetaldehyde degrading enzyme ( ALDHALDH )활성측정Activity measurement
1-1. 실험 방법1-1. Experiment method
천연물질이 숙취해소 효능이 있는지를 탐색하기 위하여 숙취해소 효능에 가장 중요한 인자인 ADH와 ALDH의 활성을 시험관 내(in vitro)에서 측정하였다.Within the natural substance is the most important factor in vitro ADH and ALDH activity of the hangover effects to search whether there is a hangover effect (in in vitro ).
효소는 동결건조된 S9 rat liver homogenate (MOLTOX Co., USA)를 0.1% 소 혈청 알부민 (bovine serum albumin) 용액 8 ml에 녹여 0.45 ㎛ 주사 필터(syringe filter)로 여과한 후 사용하였다.The enzyme was used after dissolving lyophilized S9 rat liver homogenate (MOLTOX Co., USA) in 8 ml of 0.1% bovine serum albumin solution and filtering it with a 0.45 μm injection filter.
ADH의 활성측정은 흡광도 340nm에서 NADH의 생성속도를 지표로 사용하였으며, 반응 액의 조성은 증류수 1.4 ml, 1.0 M 트리스-HCl 완충액(tris-HCl buffer)(pH 8.8) 0.75 ml, 20 mM NAD+ 0.3 ml, 에탄올(ethanol) 0.3 ml, 시료(sample) 0.1 ml의 혼합액과 효소 0.15 ml를 큐벳에 넣어 총 3ml이 되도록 하였다. 시료를 30℃에서 5분간 전처리 한 후, 340nm에서 5분 동안 흡광도 변화를 측정하였다. 이때, 시료를 첨가하지 않은 것을 대조군으로 하였으며, 시료의 ADH활성은 대조군에 대한 상대활성(%)으로서 측정하였다.The activity of ADH was measured by the rate of NADH production at the absorbance of 340 nm. The composition of the reaction solution was 1.4 ml of distilled water, 0.75 ml of 1.0 M tris-HCl buffer (pH 8.8), 20 mM NAD + 0.3 ml, 0.3 ml of ethanol, 0.1 ml of sample, and 0.15 ml of enzyme were put in a cuvette to make a total of 3 ml. After the sample was pretreated at 30 ° C. for 5 minutes, the absorbance change was measured at 340 nm for 5 minutes. At this time, the sample was not added as a control, the ADH activity of the sample was measured as relative activity (%) relative to the control.
ALDH의 활성측정은 흡광도 340nm에서 NADH의 생성속도를 지표로 사용하였으며, 반응액의 조성은 증류수 2.1 ml, 1.0 M 트리스-HCl 완충액(pH 8.0) 0.3 ml, 20 mM NAD+ 0.1 ml, 1.0 M 아세탈디하이드(acetaldehyde) 0.1 ml, 3.0 M KCl 0.1 ml, 0.33 M 2-메르캅토에탄올(mercaptoethanol) 0.1 ml, 시료 0.1 ml의 혼합액과 효소 0.1 ml를 큐벳에 넣어 총 3ml이 되도록 하였다. 시료를 30℃에서 5분간 전처리 한 후, 340nm에서 5분 동안 흡광도 변화를 측정하였다. 이때, 시료를 첨가하지 않은 것을 대조군으로 하였으며, 시료의 ALDH활성은 대조군에 대한 상대활성(%)으로서 측정하였다.The activity of ALDH was measured by the rate of NADH production at the absorbance of 340 nm. The composition of the reaction solution was 2.1 ml of distilled water, 0.3 ml of 1.0 M Tris-HCl buffer (pH 8.0), 20 mM NAD + 0.1 ml, 1.0 M acetal. 0.1 ml of dialdehyde (acetaldehyde), 0.1 ml of 3.0 M KCl, 0.1 ml of 0.33 M 2-mercaptoethanol, 0.1 ml of the sample, and 0.1 ml of enzyme were put in a cuvette to make a total of 3 ml. After the sample was pretreated at 30 ° C. for 5 minutes, the absorbance change was measured at 340 nm for 5 minutes. At this time, the sample was not added as a control, the ALDH activity of the sample was measured as relative activity (%) relative to the control.
1-2. 1-2. ADHADH 와 Wow ALDHALDH 활성도 측정 결과 Activity measurement result (( inin vitroin vitro ))
표 1은 각 식물추출물 100ppm에서의 ADH와 ALDH의 활성을 나타낸 것으로 ADH의 활성은 알로에 베라겔 추출물 118.5%, 구아바잎 추출물 114.3%, 솔잎 추출물 113.4%, 밀크티슬 추출물 107.3% 등의 순으로 나타났으며, ALDH의 활성은 전체적으로 ADH에 비하여 효소활성의 차이가 뚜렷하게 나타나지 않았다. 전체시료 가운데에서 알로에베라겔 추출물과 구아바잎 추출물이 ADH와 ALDH에서 모두 높은 효소활성을 나타내어 생체 내(in vivo) 실험에서 활성이 기대된다.Table 1 shows the activities of ADH and ALDH at 100 ppm of each plant extract. The activity of ADH was 118.5% in aloe vera gel extract, 114.3% in guava leaf extract, 113.4% in pine needle extract, and 107.3% in milk tease extract. , ALDH activity showed no significant difference in enzyme activity compared to ADH. It represented the entire sample of beragel aloe extract and guava leaf extract is high in both ADH and ALDH enzyme activity in vivo (in In vivo ) activity is expected.
실험예Experimental Example 2. 동물실험 2. Animal experiment
2-1. 숙취해소 후보물질 투여에 따른 혈중알코올 농도 감소효과 측정2-1. Measurement of Blood Alcohol Concentration Effect by Hangover Candidate Remedy
상기 시험관내(in vitro) 실험에서 수행한 숙취해소 물질을 대상으로 동물실험을 수행하였다. 동물실험은 평균 체중 30g의 흰쥐(ICR mouse) 10마리를 한 개의 실험군으로 하여 각 농도의 후보물질을 0.2 ml의 양으로 경구투여용 주사기로 구강 내에 직접 투여하고 대조군은 같은 양의 물을 경구투여 하였다. The in vitro ( in In vitro ) animal experiments were performed on the hangover-resolved substances. Animal experiments consisted of 10 rats (ICR mouse) with an average body weight of 30 g as one experimental group, and the candidate substance of each concentration was administered directly into the oral cavity with an oral syringe in an amount of 0.2 ml, and the control group was orally administered with the same amount of water. It was.
시료를 투여한지 10분이 지난 후 40% 에탄올을 0.2 ml의 양으로 경구투여하고, 그로부터 45분 및 90분 경과시 혈액을 미정맥에서 20 ㎕ 씩을 채취하여 EDTA-처리한 수기에 받은 후 즉시 6.25%의 TCA용액 180 ㎕을 가하여 2000rpm에서 10분간 원심분리하였다. 상등액 20 ㎕를 취하여 시그마사의 NAD-ADH 효소액 (Sigma-Aldrich사) 0.5 ml에 각각 넣고 이를 37℃에서 10분간 정치시킨 후 340nm에서 흡광도를 측정하였다. 이후, 에탄올 표준물질(0.05 %, 0.1 %, 0.3 %(w/v))을 이용한 에탄올 표준 셋트(ethanol standard set, Sigma kit)로 각 실험군의 혈중알코올 농도를 계산하였다.(표 2)10 minutes after the administration of the sample, 40% ethanol was orally administered in an amount of 0.2 ml, and at 45 and 90 minutes thereafter, 20 μl of blood was collected from the microvein and received in an EDTA-treated hand. 180 μl of TCA solution was added and centrifuged at 2000 rpm for 10 minutes. 20 μl of the supernatant was added to 0.5 ml of Sigma's NAD-ADH enzyme solution (Sigma-Aldrich, Inc.), respectively, which was allowed to stand at 37 ° C. for 10 minutes, and the absorbance was measured at 340 nm. Thereafter, the blood alcohol concentration of each experimental group was calculated using an ethanol standard set (Sigma kit) using ethanol standards (0.05%, 0.1%, 0.3% (w / v)) (Table 2).
상기 표 2의 결과로부터 알 수 있듯이, 숙취해소 물질의 마우스를 대상으로 한 동물실험에서 혈중알콜농도 감소효과를 측정한 결과 시험관 내(in vitro) 실험결과와 유의하게 혈중알콜농도 감소효과를 나타내었다. As can be seen from the results of Table 2, the results of measuring the blood alcohol concentration reduction in the animal experiments on mice with hangover-relieving substances in vitro ( in In vitro ) and blood alcohol concentration significantly decreased.
2-2. 숙취해소 효능에 대한 동물 실험2-2. Animal Experiments on Hangover Relief
숙취 해소 효능을 알아보기 위해, 실시예 2의 기능성 조성물을 마우스에 1 g/kg의 양으로 하여 평균 체중 30 g의 ICR 마우스(6주령)의 구강 내에 직접 투여하였다. 이 때 마우스 10마리를 한 개의 실험군으로 하였으며, 대조군에는 동일한 양의 물을 투여하였다. 시료를 투여한 지 10분이 경과 후, 40 % 에탄올 0.2 ㎖를 마우스에 경구 투여하였으며, 45분 및 90분 경과 후 미정맥에서 혈액 20 ㎕ 씩을 채취하여 EDTA-처리한 수기에 받은 후, 즉시 6.25 %의 TCA 용액 180 ㎕을 가하여 2000 rpm에서 10분간 원심분리하였다. 상등액 20 ㎕를 취하여 NAD-ADH 효소액(Sigma사) 0.5 ㎖에 넣고 이를 37 ℃에서 10분간 정치시킨 후, 340 nm에서 흡광도를 측정하였다. 이후, 에탄올 표준물질(0.05 %, 0.1 %, 0.3 %(w/v))을 이용한 에탄올 표준 셋트(ethanol standard set, Sigma kit)로 각 실험군의 혈중 알코올 농도를 계산하였다.In order to determine the hangover efficacy, the functional composition of Example 2 was administered directly to the oral cavity of an average weight 30 g of ICR mice (6 weeks old) in mice at an amount of 1 g / kg. At this time, 10 mice were used as one experimental group, and the control group was administered with the same amount of water. Ten minutes after the administration of the sample, 0.2 ml of 40% ethanol was orally administered to the mice. After 45 and 90 minutes, 20 μl of blood was collected from the caudate vein and received in an EDTA-treated hand. 180 μl of TCA solution was added and centrifuged at 2000 rpm for 10 minutes. 20 μl of the supernatant was added to 0.5 ml of NAD-ADH enzyme solution (Sigma), which was allowed to stand at 37 ° C. for 10 minutes, and the absorbance was measured at 340 nm. Then, the blood alcohol concentration of each experimental group was calculated with an ethanol standard set (Sigma kit) using ethanol standards (0.05%, 0.1%, 0.3% (w / v)).
그 결과, 도 1에 알 수 있는 것처럼, 시료를 투여한 지 45분 경과 후 대조군의 혈 중 알코올 농도는 0.13 % 인 반면, 기능성 조성물을 투여한 실험군의 혈 중 알코올 농도는 0.09 % 였으며, 90분 경과 후 대조군의 혈 중 알코올 농도는 0.08 %인 반면, 기능성 조성물을 투여한 실험군의 혈 중 알코올 농도는 0.04 %로 감소하였다. 따라서, 대조군에 비하여 본 발명의 기능성 조성물의 그 숙취해소 효능이 훨씬 탁월함이 확인되었다.As a result, as shown in Figure 1, 45 minutes after the administration of the sample, the blood alcohol concentration of the control group was 0.13%, whereas the blood alcohol concentration of the experimental group administered the functional composition was 0.09%, 90 minutes Afterwards, the blood alcohol concentration of the control group was 0.08%, whereas the blood alcohol concentration of the experimental group to which the functional composition was administered decreased to 0.04%. Accordingly, it was confirmed that the hangover efficacy of the functional composition of the present invention was much superior to the control group.
실험예Experimental Example 3. 숙취해소 기능성 조성물의 3. Hangover Relief of Functional Composition 급성독성Acute Toxicity 실험 Experiment
본 숙취해소 기능성 조성물의 안전성 실험을 위해 단회경구투여 급성독성 실험을 수행하였다. 실험동물은 쥐(Sprague Dawley outbred rats)를 사용하였으며, 암컷 5마리, 수컷 5마리는 실험군으로, 암컷 1마리, 수컷 1마리는 대조군으로 사용하였다. 기능성 조성물을 경구투여하기 전 12시간동안 사료를 금식시켰으나, 물은 충분히 공급하였다. 기능성 조성물은 쥐(SD rat) 체중 1kg 당 5g 되게 투여하였다. 기능성 조성물을 투여한 후 사료는 정상적으로 공급하였으며, 14일 동안 육안으로 쥐(rat)의 행동과 이상 징후를 관찰하였다.(표 3 및 표 4) For the safety test of the hangover functional composition, a single oral dose acute toxicity test was performed. Sprague Dawley outbred rats were used as experimental animals. Five females and five males were used as experimental groups, and one female and one male were used as controls. The food was fasted for 12 hours prior to oral administration of the functional composition, but with sufficient water. The functional composition was administered at 5 g / kg of rat rat body weight. The feed was normally supplied after administration of the functional composition, and rat behavior and abnormal signs were visually observed for 14 days (Tables 3 and 4).
급성독성 실험결과는 상기 표 3, 표 4와 같이 숙취해소 물질 투여 후 사망은 보이지 않았고, 육안 관찰시 건강상태는 양호하였으며, 체중도 정상적이었다. 14일 후 해부시 육안 검사결과 각 조직기관에 어떠한 이상도 나타나지 않았으므로 기능성 조성물이 안전하다는 것을 알 수 있었다. As a result of the acute toxicity test, as shown in Table 3 and Table 4, there was no death after the hangover administration, and the visual condition was good and the body weight was normal. 14 days later, the dissection showed that the functional composition was safe because no abnormalities were observed in each tissue.
실험예Experimental Example 4. 숙취해소 효능에 대한 임상실험 4. Clinical trial on hangover relief
상기 실시예 2에서 제조한 기능성 조성물의 숙취해소 효능을 측정하기 위하여, 건강한 20-30대 성인남녀 40명(표 5참조)을 대상으로 하기와 같은 방법으로 3회에 걸쳐 실험하여 평균값을 계산하였다. 먼저 15분간 소주 반병(알콜도수 22도, 참이슬, 한국) 180 ㎖와 쏘시지 3조각을 섭취하고, 10분 후 실험군에는 상기 실시예 2의 기능성 조성물 100 ㎖(1% 농도)와 대조군에는 동일한 부피의 위약(생수)을 복용하게 한 다음, 섭취가 끝난 후 30분 및 2시간 후에 정맥 채혈을 수행하여 혈중 알코올농도를 측정하였다. 또한, 자각증상을 평가하기 위하여 알코올 섭취 후 30분, 1시간, 3시간, 5시간 경과한 시점에서 설문조사 수행하였다.In order to measure the hangover efficacy of the functional composition prepared in Example 2, 40 healthy males and females in their 20s and 30s (see Table 5) were tested three times in the following manner to calculate the average value. . First, take a half bottle of soju (alcohol number 22 degrees, Chamomile, Korea) for 15 minutes and three pieces of sausage, and after 10 minutes, 100 ml (1% concentration) of the functional composition of Example 2 in the experimental group and the same volume in the control group After taking the placebo (bottled water), the blood alcohol concentration was measured by
그 결과, 도 2에서 나타낸 바와 같이, 각 시료 섭취 30 분 후 대조군의 혈중 알코올 농도는 0.09 % 였고, 기능성 조성물을 섭취한 실험군의 혈중 알코올 농도는 0.08 % 였다. 섭취 120 분 후, 대조군의 혈중 알코올 농도는 0.07 % 인 반면, 기능성 조성물을 섭취한 실험군의 혈중 알코올 농도는 0.02 %로 급격히 감소하였다. 따라서, 기능성 조성물이 대조군에 비해 뚜렷한 숙취해소 효과를 나타냄을 확인할 수 있었다.As a result, as shown in FIG. 2, the blood alcohol concentration of the control group was 0.09% after 30 minutes of ingestion of each sample, and the blood alcohol concentration of the experimental group ingesting the functional composition was 0.08%. After 120 minutes of ingestion, the blood alcohol concentration of the control group was 0.07%, while the blood alcohol concentration of the experimental group ingesting the functional composition decreased to 0.02%. Therefore, it was confirmed that the functional composition showed a clear hangover effect compared to the control.
또한, 설문조사 결과 기능성 조성물이 확실한 숙취해소 효능을 가지고 있음을 알 수 있었다. 설문조사 결과는 표 6과 같다.In addition, the survey showed that the functional composition has a clear hangover efficacy. The survey results are shown in Table 6.
제제예Formulation example 1. 건강 식품의 제조 1. Manufacture of healthy food
실시예 2의 기능성 조성물......................1000 ㎎Functional composition of Example 2 ... 1000 mg
비타민 혼합물..................................20 gVitamin Blend ......................... 20 g
비타민 A 아세테이트............................70 ㎍Vitamin A Acetate ............... 70 μg
비타민 E......................................1.0 ㎎Vitamin E ...................................... 1.0 mg
비타민 B1..........................................................0.13 ㎎Vitamin B 1 ...... ........... 0.13 mg
비타민 B2..........................................................0.15 ㎎Vitamin B 2 ...... ........... 0.15 mg
비타민 B6..........................................................0.5 ㎎Vitamin B 6 ... ........... 0.5 ㎎
비타민 B12.........................................................0.2 ㎍Vitamin B 12 ... .......... 0.2 ㎍
비타민 C.......................................10 ㎎Vitamin C ......................................... 10 mg
비오틴.........................................10 ㎍Biotin ......................................... 10 μg
니코틴산아미드.................................1.7 ㎎Nicotinic Acid Amide ... 1.7 mg
엽산...........................................50 ㎍Folic acid ......................................... 50 ㎍
판토텐산 칼슘.................................0.5 ㎎Calcium Pantothenate ......... 0.5 mg
무기질 혼합물.................................적 량Mineral mixture ..................
황산제1철.....................................1.75 ㎎Ferrous Sulfate ........................ 1.75 mg
산화아연......................................0.82 ㎎Zinc Oxide ......................................... 0.82 mg
탄산마그네슘..................................25.3 ㎎Magnesium Carbonate ......................................... 25.3 mg
제1인산칼륨....................................15 ㎎Potassium monophosphate ......................................... 15 mg
제2인산칼슘....................................55 ㎎Dicalcium Phosphate Diluent ... 55 mg
구연산칼륨.....................................90 ㎎Potassium Citrate ............... 90 mg
탄산칼슘.......................................100 ㎎Calcium Carbonate ... 100 mg
염화마그네슘..................................24.8 ㎎Magnesium Chloride ......................................... 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강식품에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강식품 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강식품 조성물 제조에 사용할 수 있다.Although the composition ratio of the above-mentioned vitamin and mineral mixtures is mixed with a component suitable for a health food in a preferred embodiment, the compounding ratio may be arbitrarily modified, and the above ingredients are mixed according to a conventional health food manufacturing method. The granules may be prepared and used for preparing a health food composition according to a conventional method.
제제예Formulation example 2. 건강 음료의 제조 2. Manufacture of health drinks
실시예 2의 기능성 조성물..................1000 ㎎Functional composition of Example 2 .. 1000 mg
구연산....................................1000 ㎎Citric Acid ......................................... 1000 mg
올리고당...................................100 gOligosaccharide ......................... 100 g
매실농축액...................................2 gPlum concentrate ........................... 2 g
타우린.......................................1 gTaurine ......................................... 1 g
정제수를 가하여 전체......................900 ㎖Purified water is added to the whole ..... 900 ml
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1시간동안 85 ℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 ℓ 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 건강음료 조성물 제조에 사용한다. After mixing the above components in accordance with the conventional healthy beverage manufacturing method, and stirred and heated at 85 ℃ for about 1 hour, the resulting solution is filtered and obtained in a sterilized 2 L container, sealed sterilization and refrigerated Used to prepare the healthy beverage composition of the invention.
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용 용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다. Although the composition ratio is a composition suitable for a preferred beverage in a preferred embodiment, the composition ratio may be arbitrarily modified according to regional and ethnic preferences such as demand hierarchy, demand country, use purpose.
본 발명에 따른 알로에베라겔 추출물, 에피갈로카테킨갈레이트(EGCG), 솔잎 추출물, 구아바잎 추출물, 비타민 C 및 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 하고, 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물은 숙취해소에 뛰어난 효과를 나타내므로, 이를 유효성분으로 함유하는 식품, 식품첨가제 또는 건강기능식품으로 제품화되어 현대인의 음주 후 숙취 예방 및 개선에 유용하고 간편하게 이용될 수 있다. Aloe vera gel extract, epigallocatechin gallate (EGCG), pine needle extract, guava leaf extract, vitamin C and vitamin B 2 according to the present invention as a main ingredient, a combination of milk teal extract, jinjin mugwort extract, fingering Functional composition for preventing and improving hangover containing mushroom extract as an additional ingredient shows excellent effect on relieving hangover, and is commercialized as a food, food additive or health functional food containing it as an active ingredient to prevent and improve hangover after drinking It can be useful and convenient to use.
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050086889A KR100690071B1 (en) | 2005-09-16 | 2005-09-16 | Functional composition for the prevention and improvement of hangover |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050086889A KR100690071B1 (en) | 2005-09-16 | 2005-09-16 | Functional composition for the prevention and improvement of hangover |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100690071B1 true KR100690071B1 (en) | 2007-03-08 |
Family
ID=38102497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050086889A KR100690071B1 (en) | 2005-09-16 | 2005-09-16 | Functional composition for the prevention and improvement of hangover |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100690071B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101093998B1 (en) * | 2009-03-26 | 2011-12-15 | 주식회사 벤스랩 | Functional composition for the prevention of hangover and improving liver function |
KR20180134481A (en) * | 2017-06-09 | 2018-12-19 | 동부생약 영농조합법인 | Method for producing mixed extract of Dendropanax morbifera, Hovenia dulcis, Coriolus versicolor, Artemisia capillaris and Oenanthe javanica using response surface methodology |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960016779A (en) * | 1994-11-14 | 1996-06-17 | 강성훈 | Health mixed drink composition |
JPH08169831A (en) * | 1994-12-16 | 1996-07-02 | Itouen:Kk | Agent for promoting metabolism of alcohol in body and its production |
KR20010036048A (en) * | 1999-10-05 | 2001-05-07 | 천경호 | Beverage composition for protection drunkage |
KR20050035003A (en) * | 2003-10-11 | 2005-04-15 | 주식회사 벤스랩 | Functional composition for the prevention and improvement of smoking abuses and hangover |
-
2005
- 2005-09-16 KR KR1020050086889A patent/KR100690071B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960016779A (en) * | 1994-11-14 | 1996-06-17 | 강성훈 | Health mixed drink composition |
JPH08169831A (en) * | 1994-12-16 | 1996-07-02 | Itouen:Kk | Agent for promoting metabolism of alcohol in body and its production |
KR20010036048A (en) * | 1999-10-05 | 2001-05-07 | 천경호 | Beverage composition for protection drunkage |
KR20050035003A (en) * | 2003-10-11 | 2005-04-15 | 주식회사 벤스랩 | Functional composition for the prevention and improvement of smoking abuses and hangover |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101093998B1 (en) * | 2009-03-26 | 2011-12-15 | 주식회사 벤스랩 | Functional composition for the prevention of hangover and improving liver function |
KR20180134481A (en) * | 2017-06-09 | 2018-12-19 | 동부생약 영농조합법인 | Method for producing mixed extract of Dendropanax morbifera, Hovenia dulcis, Coriolus versicolor, Artemisia capillaris and Oenanthe javanica using response surface methodology |
KR101993709B1 (en) | 2017-06-09 | 2019-06-26 | 동부생약 영농조합법인 | Method for producing mixed extract of Dendropanax morbifera, Hovenia dulcis, Coriolus versicolor, Artemisia capillaris and Oenanthe javanica using response surface methodology |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8084061B2 (en) | Body fat-reducing agent | |
JP2006188486A (en) | Body fat accumulation-inhibiting or reducing agent | |
KR102020586B1 (en) | Healthy foods for elderly comprising animal and plant extracts and process for preparation thereof | |
KR102448542B1 (en) | Composition for relieving menopausal symptom | |
KR101093998B1 (en) | Functional composition for the prevention of hangover and improving liver function | |
KR20100128941A (en) | Functional composition for the prevention and improvement of hangover, and food and food additive having the same | |
KR101565964B1 (en) | Composition Comprising Water Extracts from Pleurotus eryngii var. ferulea (Pf.). for Treating or Preventing hyperlipidemia | |
KR100690071B1 (en) | Functional composition for the prevention and improvement of hangover | |
KR100768830B1 (en) | Extract of echinosophora koreensis removing hangover and having anti-oxidant activity | |
KR102437419B1 (en) | Composition for removing hangover | |
KR102366919B1 (en) | Functional health food composition for inhibiting muscle reduction comprising a mixed extract of mulberry twig, Eucommia bark, Acanthopanax, and black bean | |
KR101210748B1 (en) | Composition comprising the extract of Acanthopanax sessiliflorus and green tea for treating or alleviating hangover syndrome | |
KR100570959B1 (en) | Functional Food Composition showing Anti-allergic rhinitis, Anti-atopic dermatitis and Anti-chronic asthma activity | |
KR100510253B1 (en) | Functional Food Composition having Anti-oxidative, Anti-arthritic and Anti-dementia Activity | |
KR100872310B1 (en) | Functional composition for the cotinene metabolism improvement which is caused by with smoking and hangover removal, foods and food additive containing the same | |
KR101636608B1 (en) | Composition for antioxidation comprising the seed extract of cornus officinalis | |
KR20170077980A (en) | Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill. | |
KR20150120741A (en) | Composition for preventing or improving atopic dermatitis comprising mixture of persimmon peel, persimmon flesh, persimmon leaf and Diospyros lotus leaf as effective component | |
KR100551464B1 (en) | Composition comprising an extract of Saururus chinensis BAILL. for preventing and treating diabetes mellitus | |
KR20190125616A (en) | Method for producing inner beauty beverage using Chrysanthemum zawadskii and fermeted Rhus verniciflua | |
KR102275824B1 (en) | The anti-diabetes composition containing extract mixture and manufaturing method thereof | |
KR102302047B1 (en) | Composition for hepatoprotective and ameliorating hangover | |
WO2006033496A1 (en) | Functional composition for the prevention and alleviation of hangover | |
KR20180006612A (en) | Compositions for preventing or treating diabetes mellitus comprising extract of Aster koraiensis or fraction thereof | |
KR20220001315A (en) | A composition comprising an extract of Thymus quinquecostatus Celak for treating and preventing hangover |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130226 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140226 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150223 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160224 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170221 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190131 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20200226 Year of fee payment: 14 |